Trademark: 97532215
Status Date
Wednesday, February 7, 2024
Filing Date
Wednesday, August 3, 2022
Published for Opposition
Tuesday, December 13, 2022
5 Medical diagnostic reagents and medical diagnostic kits comprised of medical diagnostic reagents; reagents for medical use and medical diagnostics or screening kits comprised of reagents for medical diagnostics or screening use; reagents for use in genetic testing for medical and medical diagnostic purposes; diagnostic preparations for medical purposes; assays, reagents, enzymes, and nucleotides for medical or clinical diagnostics or screening purposes; diagnostic assays, reagents, enzymes, and nucleotides for medical or clinical purposes
1 Assays, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, or research purposes; diagnostic or screening assays, reagents, enzymes, and nucleotides for clinical or medical laboratory, scientific, or research purposes; reagents for medical and genetic research use; chemical reagents and diagnostic preparations for clinical or medical laboratory use
44 Genetic testing and reporting for medical purposes; medical testing for diagnostic or treatment purposes; medical screening; medical diagnostic testing, monitoring and reporting services; providing a website featuring medical information regarding genetics; genetic analysis and reporting services for medical purposes
10 Testing instruments for medical diagnostic purposes, namely, apparatus for the analysis of body fluids, tissue samples and liquid biopsies
42 Scientific and medical research services; providing an online database in the field of genetics and cancer for medical or scientific research; providing temporary use of on-line non-downloadable software and applications for use in studying, diagnosing or screening for cancer and studying genetics and DNA; providing temporary use of on-line non-downloadable cloud computing software for use in studying, diagnosing or screening cancer and studying genetics and DNA; providing temporary use of on-line non-downloadable software and applications for use in studying, diagnosing or screening for cancer; providing temporary use of on-line non-downloadable cloud computing software for use in studying, diagnosing or screening cancer; Software as a Service (SaaS) services featuring software in the nature of a platform for genetic and bioinformatics analysis
The mark consists of a stylized tear drop design.
Color is not claimed as a feature of the mark.
Feb 9, 2024
Notice Of Approval Of Extension Request E-Mailed
Feb 7, 2024
Sou Extension 2 Granted
Feb 7, 2024
Sou Extension 2 Filed
Feb 7, 2024
Sou Teas Extension Received
Sep 14, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Sep 14, 2023
Teas Change Of Correspondence Received
Sep 14, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 14, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Aug 9, 2023
Notice Of Approval Of Extension Request E-Mailed
Aug 7, 2023
Sou Extension 1 Granted
Aug 7, 2023
Sou Extension 1 Filed
Aug 7, 2023
Sou Teas Extension Received
Jun 17, 2023
Teas Change Of Correspondence Received
Jun 17, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Jun 17, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jun 17, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 17, 2023
Teas Change Of Owner Address Received
Feb 7, 2023
Noa E-Mailed - Sou Required From Applicant
Dec 13, 2022
Official Gazette Publication Confirmation E-Mailed
Dec 13, 2022
Published For Opposition
Nov 23, 2022
Notification Of Notice Of Publication E-Mailed
Nov 10, 2022
Approved For Pub - Principal Register
Nov 5, 2022
Assigned To Examiner
Aug 25, 2022
Notice Of Design Search Code E-Mailed
Aug 24, 2022
New Application Office Supplied Data Entered
Aug 6, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
